pharmaceutical investing Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX for Injection
pharmaceutical investing Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares
pharmaceutical investing Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX for Injection
pharmaceutical investing Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
pharmaceutical investing Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX for Injection
Kobo Resources Announces Non-Brokered Private Placement of up to $5.5 Million to Advance Kossou and Regional Growth
Gold Runner Exploration Upsizes Non-Brokered Private Placement Financing of Flow-Through Units and Charity Flow Through Units to $3,100,000
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program
Brunswick Exploration Closes Final Tranche of Non-Brokered Private Placement for Total Gross Proceeds of $5,445,000
